Passage Bio, Inc. Common Stock
Symbol: PASG (NASDAQ)
0.00
▼ (-100.00%) -8.195
Company Description:
Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease. The Company operates in a single reportable segment, developing and advancing genetic medicines designed to target critical underlying pathology of neurodegenerative diseases.
Key Stats
- Today's Open: $0
- Today's High: $0
- Today's Low: $0
- Today's Volume: 0
- Yesterday Close: $8.195
- Yesterday High: $8.9499
- Yesterday Low: $7.92
- Yesterday Volume: 58.65K
- Last Min Volume: 0
- Last Min High: $0
- Last Min Low: $0
- Last Min VWAP: $0
Company Profile
- Name: Passage Bio, Inc. Common Stock
- Website: https://www.passagebio.com
- Listed Date: 2020-02-28
- Location: PHILADELPHIA, PA
- Market Status: Active
- CIK Number: 0001787297
- SIC Code: 2836
- SIC description: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
- Market Cap: $27.81M
- Round Lot: 100
- Outstanding Shares: 3.18M
- Asset Type: CS
RECENT FILINGS FOR PASG
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-18 | 8-K | View |
| 2025-09-15 | 4 | View |
| 2025-08-12 | 10-Q | View |
| 2025-08-12 | 8-K | View |
| 2025-07-29 | 8-K | View |
| 2025-07-24 | 4 | View |
| 2025-07-24 | SCHEDULE 13D/A | View |
| 2025-07-21 | 144 | View |
| 2025-07-21 | SCHEDULE 13D/A | View |
| 2025-07-15 | 144 | View |
| 2025-07-14 | 8-K | View |
| 2025-07-09 | SCHEDULE 13D/A | View |
| 2025-07-07 | 144 | View |
| 2025-06-26 | 4 | View |
| 2025-06-24 | 144 | View |
| 2025-06-23 | 8-K | View |
| 2025-05-30 | 4 | View |
| 2025-05-30 | 4 | View |
| 2025-05-30 | 4 | View |
| 2025-05-30 | 4 | View |
Latest News on PASG